← All drugs Report issue

anbalcabtagene autoleucel

Cell therapyexperimental

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

B-lymphocyte antigen CD19Immunity, passive
CD19 immunity, passive
- B-lymphocyte antigen CD19 (CD19) ↗

Chemistry & pharmacology

Chirality: Single Stereoisomer
Inorganic: No
Polymer: No

Oral

No

Parenteral

No

Topical

No

Sources

ChEMBLCHEMBL5314655 ↗